Remnant Ablation With I-131 in an Anuric Haemodialysis Patient
A 59-year-old man with a 4.2 cm papillary thyroid carcinoma, pT3aN1b, has undergone total thyroidectomy and is referred for remnant ablation. He has end-stage renal disease from diabetic nephropathy and has been on haemodialysis three times weekly for four years; he is anuric. His stimulated TSH is 96 mIU/L, thyroglobulin 18 ng/mL with negative anti-thyroglobulin antibodies, and his postoperative neck ultrasound shows residual tissue in the thyroid bed but no suspicious nodes. He weighs 88 kg and his eGFR is under 10 mL/min/1.73 m². The referring endocrinologist has requested 3.7 GBq (100 mCi). His dialysis unit is 30 km away, his wife is his only caregiver and they have no children at home, and the dialysis nurses have already told him they are "not licensed to handle radioactive patients." He wants to know whether he can be treated as an outpatient and simply attend dialysis the next morning as usual.
1. Critique the requested activity and describe the dosimetry reasoning that would justify changing it.
Read the worked answer
The requested 3.7 GBq was chosen for a risk category, not for this patient's physiology, and the physiology dominates here.
In a normally functioning kidney, iodine is excreted rapidly and whole-body retention falls with an effective half-life of roughly a day. In an anuric dialysis patient, there is essentially no renal excretion, so the iodine stays in the blood and tissue compartments far longer. Whole-body and red-marrow residence times rise several-fold, and the marrow absorbed dose can approach or exceed levels associated with prolonged cytopenias. The same administered activity therefore delivers substantially more marrow dose than it would in the patient the 3.7 GBq figure was derived from.
Reasonable approach:
- Reduce the activity. Roughly half (about 1.85 GBq) is a common starting point for ablation in dialysis-dependent patients, with the exact figure set by dosimetry where available.
- If your centre can do it, use pre-treatment dosimetry with blood and whole-body retention measurements to target a marrow dose (commonly around 2 Gy) rather than a fixed activity, and repeat the retention measurements after administration.
- Plan dialysis within 24-48 hours of administration: dialysis removes circulating iodide efficiently and will reduce the retained activity faster than the patient can himself.
- Confirm stimulation adequacy (his TSH of 96 is adequate) and note that recombinant TSH is often preferred in renal failure as a convenience, though his anuria removes the usual concern about hypothyroidism further reducing renal function.
Do not simply accept the referring activity without a documented reassessment.
2. Can he be treated as an outpatient? Walk through the release decision and the practical radiation safety constraints.
Read the worked answer
No. He cannot meet release criteria.
The release test is that the total effective dose equivalent to any other individual from exposure to the released patient is not likely to exceed 5 mSv. A commonly used surrogate is a measured dose rate at 1 m of about 70 microsieverts per hour or less. With no renal excretion, his dose rate at 1 m will remain well above that for days, and his wife - who is his sole caregiver and shares a home - would exceed 5 mSv comfortably. He must be admitted to a radiation-isolation room with controlled access, and the release decision must be documented with a measured dose rate and an estimate for the wife, not assumed.
Dialysis logistics:
- He must be dialysed during the admission, either in a designated inpatient setting or under a written protocol agreed in advance with the outpatient unit.
- The dialysate circuit is separate from the blood circuit, but iodide crosses the dialyser, so the effluent will contain I-131. Assay it. Dialysate flow is typically hundreds of millilitres per minute, so the activity is heavily diluted, but the discharge must still be shown to meet the applicable sewer concentration limit, or the effluent held for decay.
- The dialyser and lines are contaminated and must be handled as radioactive waste.
- Staff performing dialysis will receive a small dose; issue dosimeters and written instructions, and brief them before the session.
3. What do you tell the patient and the dialysis staff, and what written instructions do you provide?
Read the worked answer
Speak to both groups separately and put everything in writing.
To the patient and his wife: explain that the activity is lower than the endocrinologist requested because his kidneys cannot clear iodine, and that this is a safety adjustment, not a downgrade in his cancer treatment. Explain why he must be admitted, roughly how long, and what the isolation will involve. Give the wife written instructions covering: sleeping in a separate bed, maintaining distance where practical, avoiding prolonged close contact and holding, not sharing utensils or towels, using gloves for any contact with body fluids, and the specific end date of the precautions. Give her a realistic expectation - expect longer than the usual week because of his prolonged retention - and a 24-hour RSO contact number.
To the dialysis staff: a signed, pre-agreed protocol stating the measured dose rate at 1 m and at contact, the expected duration, the handling of the dialyser, lines, and effluent, the fact that the machine itself is not a contamination problem once the circuit is disconnected if handled correctly, and the dosimetry arrangements. Address their concern directly rather than dismissing it; "not licensed" is a training and protocol gap, not a legal barrier, and it is your job as RSO to close it before the patient arrives.
Document the counselling, the written instructions issued, and the dialysis unit's signed acceptance.